Cell Lysis Dissociation Market By Product (Mechanical Disruption, Chemical Disruption, Enzymatic Digestion, Other), By End-Use (Research Laboratories, Biopharmaceutical Companies, Contract Research Organizations, Others), and By Region Forecast to 2032

The global cell lysis dissociation market size was USD 4.86 Billion in 2022 and is expected register a revenue CAGR of 9% during the forecast period.

Key Pointers

• The mechanical disruption segment is expected to account for largest revenue share during the forecast period due to its greater efficacy in cell lysis and dissociation operations.
• The chemical disruption segment is expected to register fastest revenue CAGR during the forecast period. 
• The Contract Research Organizations (CROs) segment is expected to register fastest revenue CAGR during the forecast period.
• The market in North America is expected to account for largest revenue share during the forecast period.
• The market in Asia Pacific is expected to register fastest revenue CAGR during the forecast period.
• The market in Europe is expected to account for second largest revenue share during the forecast period.

Rising demand for cell-based assays in research and development, increasing prevalence of chronic and infectious diseases, and technological developments in cell lysis and dissociation products are major factors driving market revenue growth.

Products from cell lysis and dissociation are widely employed in a variety of applications, including protein isolation, gene expression investigations, and drug development, among others. Moreover, demand for cell lysis and dissociation products is being driven by rising investments in the biotechnology and pharmaceutical industries.

Moreover, demand for cell lysis and dissociation products is expected to rise in response to increased interest in personalized medicine and regenerative medicine. In the process of creating personalized medicine, which entails examining a patient's genetic profile to establish individualized treatment options, cell lysis and dissociation are crucial phases. Moreover, materials resulting from cell lysis and dissociation are employed to create cell-based therapeutics and regenerative medicine products. Demand for cell lysis and dissociation products is also expected to rise as chronic and infectious diseases become more common. Cancer, Alzheimer's disease, and diabetes are just a few of the illnesses that are diagnosed and treated using cell-based assays.

Moreover, technological developments in products for cell lysis and dissociation are driving revenue growth of the market. It is expected that the adoption of these products in various research and development applications would rise with the development of novel reagents and kits that offer effective cell lysis and dissociation. For instance, it is expected that in the coming years, demand for these goods would rise as a result of the development of bead-based cell lysis solutions that enable quick and effective cell lysis.

Aside from this, revenue growth of the market is also being driven by rising adoption of automation in cell lysis and dissociation. Automating the cell lysis and dissociation processes improves efficiency by lowering human error. Another factor driving adoption of automated cell lysis and dissociation systems is rising demand for high-throughput screening in drug discovery and development. In the coming years, it is also expected that use of these products will expand with the creation of integrated systems that combine cell lysis and dissociation with subsequent processing processes.

High cost of cell lysis and dissociation products; however, could restrain revenue growth of the market. Also, it is expected that the complexity of cell lysis and dissociation operations and a shortage of qualified professionals could restrain revenue growth of the market. Other cell lysis and dissociation techniques, such as sonication and freeze-thaw cycles, are also expected to hamper revenue growth of the market.

Major Companies and Competitive Landscape:

Some of the major companies operating in the cell lysis dissociation market are:

• Thermo Fisher Scientific Inc.
• Merck KGaA
• QIAGEN N.V.
• Bio-Rad Laboratories, Inc.
• Becton, Dickinson and Company
• Miltenyi Biotec
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation
• Promega Corporation
• Lonza Group

Cell Lysis Dissociation Market Segmentations: